Greenwich Health Dept warns against ‘several viruses’, as Pfizer’s stock tumbles

Following the CDC’s directives, the Greenwich Health department warned residents of several viruses circulating, and cautioned against the most common Covid-19 variant, JN.1.

Excerpt:

“A January 19 CDC update detailed that many people are getting co-infected with more than one respiratory virus at a time including coming down with different strains of influenza (Information for the 2023-2024 Flu Season | CDC).

JN.1 doesn’t make you sicker than prior versions, but it is much more contagious so you can make many others ill if you expose them. The CDC has issued projections that the JN.1 variant is going to continue to increase as a proportion of all the circulating COVID-19 viruses (Update on SARS-CoV-2 Variant JN.1 Being Tracked by CDC | CDC), thus supporting the public health call to action that people get vaccinated with the latest COVID-19 vaccine/booster that became available to us in the Fall of 2023, and that people take adequate precautions to avoid making others sick.” –read more: Greenwich Health Dept: Respiratory Viruses Remain Active in Connecticut

The Greenwich health department updated the rates of positive tests, 7-day cases, and percent vaccinated on May 3rd, 2023:

Greenwich’s higher vaccination rate did not seem to mitigate test positivity; and other metrics such as infection or infection fatality rates (IFR) are not given.

While cases, hospitalizations, and deaths are displayed later in the original article, it is unknown if cases, hospitalizations, and/or deaths, included those who received Pfizer’s shots.

Health officials’ push to vaccinate arrives as Pfizer’s stock, while experiencing a tiny rebound in the past few days, has fallen sharply from nearly $49 per share, down to $27.

Pfizer’s five-day decline: -2.86%

Pfizer’s year-long decline: -36.85%

Pfizer’s Comirnaty shot generated nearly 38% of the company’s revenue in 2022, dwarfing other profitable pharma products.